Table 2.
Clinical characteristics of HS patients in regard to the Hurley stage of Hidradenitis suppurativa.
| Characteristic | Median ± QD | p-Value | |||||
|---|---|---|---|---|---|---|---|
| Hurley Stage of HS | Kruskal–Wallis | I vs. II | I vs. III | II vs. III | |||
| I | II | III | |||||
| EQ-5D-5L before, points | 40.00 ± 20.00 | 60.00 ± 0.00 | 50.00 ± 10.00 | 0.024 | 0.031 | 1.000 | 0.059 |
| EQ-5D-5L after, points | 100.00 ± 10.00 | 100.00 ± 0.50 | 90.00 ± 5.00 | 0.208 | - | - | - |
| BMI | 26.60 ± 4.35 | 33.50 ± 1.15 | 30.80 ± 1.80 | 0.085 | - | - | - |
| Age, years | 22.00 ± 0.50 | 45.00 ± 4.50 | 42.00 ± 2.00 | 0.033 | 0.068 | 0.076 | 1.000 |
| Time from first symptoms to final diagnosis, years | 1.00 ± 0.50 | 15.00 ± 2.00 | 12.00 ± 4.00 | 0.001 | 0.001 | 0.014 | 0.296 |
| Time of hospitalization, days | 4.00 ± 1.00 | 4.00 ± 1.00 | 7.00 ± 1.50 | 0.014 | 1.000 | 0.023 | 0.306 |
| Duration of disease, years | 4.00 ± 1.50 | 16.00 ± 2.50 | 14.00 ± 4.50 | 0.005 | 0.011 | 0.026 | 0.737 |
Legend: HS, hidradenitis suppurativa, BMI, body mass index; EQ-5D-5L, questionnaire of health-related life quality; QD, quartile deviation.